^
BIOMARKER:

EGFR amplification

i
Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
EGFR amplification
Non Small Cell Lung Cancer
gefitinib
Sensitive
:
B
EGFR amplification
Squamous Cell Carcinoma of Head and Neck
afatinib
Sensitive
:
B
EGFR amplification
Non Small Cell Lung Cancer
erlotinib
Sensitive
:
C2
EGFR amplification
Glioblastoma
ABT-414
Sensitive
:
C2
EGFR amplification
Glioblastoma
lapatinib
Sensitive
:
C2
EGFR amplification
Esophageal Squamous Cell Carcinoma
afatinib
Sensitive
:
C2
EGFR amplification
Glioblastoma
KD019
Sensitive
:
C2
EGFR amplification
Glioma
ABT-414
Sensitive
:
C2
EGFR amplification
Squamous Cell Carcinoma of Head and Neck
Immunotherapy
Resistant
:
C3
EGFR amplification
Gastric Cancer
cetuximab
Sensitive
:
C3
EGFR amplification
Glioblastoma
erlotinib
Resistant
:
C3
EGFR amplification
Melanoma
Immunotherapy
Resistant
:
C3
EGFR amplification
Mucosal Melanoma
ipilimumab
Resistant
:
C3
EGFR amplification
Mucosal Melanoma
nivolumab
Resistant
:
C3
EGFR amplification
Mucosal Melanoma
nivolumab + ipilimumab
Resistant
:
C3
EGFR amplification
Mucosal Melanoma
pembrolizumab
Resistant
:
C3
EGFR amplification
Colorectal Cancer
cetuximab
Resistant
:
C3
EGFR amplification
Colorectal Cancer
panitumumab
Sensitive
:
C3
EGFR amplification
Non Small Cell Lung Cancer
osimertinib
Resistant
:
C3
EGFR amplification
Solid Tumor
ABSK091
Sensitive
:
C3
EGFR amplification
Lung Cancer
gefitinib
Resistant
:
C3
EGFR amplification
Lung Cancer
icotinib
Resistant
:
C3
EGFR amplification
Non Small Cell Lung Cancer
bevacizumab + erlotinib
Sensitive
:
C3
EGFR amplification
Non Small Cell Lung Cancer
bevacizumab + gefitinib
Sensitive
:
C3
EGFR amplification
Squamous Cell Carcinoma of Head and Neck
pembrolizumab + afatinib
Sensitive
:
C3
EGFR amplification
Gastric Cancer
EGFR inhibitor
Sensitive
:
C3
EGFR amplification
Esophageal Cancer
EGFR inhibitor
Sensitive
:
C3
EGFR amplification
Non Small Cell Lung Cancer
KN046
Sensitive
:
C3
EGFR amplification
Esophageal Squamous Cell Carcinoma
Z650
Sensitive
:
C3
EGFR amplification
Lung Adenocarcinoma
afatinib
Sensitive
:
C4
EGFR amplification
Triple Negative Breast Cancer
cetuximab
Sensitive
:
C4
EGFR amplification
Glioblastoma
verteporfin
Sensitive
:
D